Abstract
Thiosemicarbazones are biological active compounds. In this work, five new thiosemicarbazones were prepared and structurally characterized by elemental analysis, 1H NMR and IR spectra, as well as single crystal X-ray diffraction. The compounds were evaluated for their urease inhibitory activities. Among the compounds, those with hydroxyl substituent groups have effective activity with IC50 values of 1.5-2.3 μmol/L. Docking simulation was performed to insert the molecules of the compounds into the crystal structure of Jack bean urease at the active site to determine their probable binding modes.
REFERENCES
L. V. Modolo, A. X. de Souza, L. P. Horta, D. P. Araujo, and Â. de Fátima. An overview on the potential of natural products as ureases inhibitors: A review. J. Adv. Res., 2015, 6(1), 35-44. https://doi.org/10.1016/j.jare.2014.09.001
H. Cantarella, R. Otto, J. R. Soares, and A. G. de B. Silva. Agronomic efficiency of NBPT as a urease inhibitor: A review. J. Adv. Res., 2018, 13, 19-27. https://doi.org/10.1016/j.jare.2018.05.008
M. Kazmi, I. Khan, A. Khan, S. A. Halim, A. Saeed, S. Mehsud, A. Al-Harrasi, and A. Ibrar. Developing new hybrid scaffold for urease inhibition based on carbazole-chalcone conjugates: Synthesis, assessment of therapeutic potential and computational docking analysis. Bioorg. Med. Chem., 2019, 27(22), 115123. https://doi.org/10.1016/j.bmc.2019.115123
Q. Liu, W.-K. Shi, S.-Z. Ren, W.-W. Ni, W.-Y. Li, H.-M. Chen, P. Liu, J. Yuan, X.-S. He, J.-J. Liu, P. Cao, P.-Z. Yang, Z.-P. Xiao, and H.-L. Zhu. Arylamino containing hydroxamic acids as potent urease inhibitors for the treatment of Helicobacter pylori infection. Eur. J. Med. Chem., 2018, 156, 126-136. https://doi.org/10.1016/j.ejmech.2018.06.065
W.-K. Shi, R.-C. Deng, P.-F. Wang, Q.-Q. Yue, Q. Liu, K.-L. Ding, M.-H. Yang, H.-Y. Zhang, S.-H. Gong, M. Deng, W.-R. Liu, Q.-J. Feng, Z.-P. Xiao, and H.-L. Zhu. 3-Arylpropionylhydroxamic acid derivatives as Helicobacter pylori urease inhibitors: Synthesis, molecular docking and biological evaluation. Bioorg. Med. Chem., 2016, 24(19), 4519-4527. https://doi.org/10.1016/j.bmc.2016.07.052
W.-Q. Song, M.-L. Liu, S.-Y. Li, and Z.-P. Xiao. Recent efforts in the discovery of urease inhibitor identifications. Curr. Top. Med. Chem., 2022, 22(2), 95-107. https://doi.org/10.2174/1568026621666211129095441
M. Liu, W. Li, H. Fang, Y. Ye, S. Li, W. Song, Z. Xiao, H. Ouyang, and H. Zhu. Synthesis and biological evaluation of dithiobisacetamides as novel urease inhibitors. ChemMedChem, 2022, 17(2). https://doi.org/10.1002/cmdc.202100618
W.-W. Ni, H.-L. Fang, Y.-X. Ye, W.-Y. Li, L. Liu, Z.-J. Fu, Dawalamu, W.-Y. Zhu, K. Li, F. Li, X. Zou, H. Ouyang, Z.-P. Xiao, and H.-L. Zhu. Synthesis and structure-activity relationship studies of N-monosubstituted aroylthioureas as urease inhibitors. Med. Chem., 2021, 17(9), 1046-1059. https://doi.org/10.2174/1573406416999200818152440
W.-Y. Li, W.-W. Ni, Y.-X. Ye, H.-L. Fang, X.-M. Pan, J.-L. He, T.-L. Zhou, J. Yi, S.-S. Liu, M. Zhou, Z.-P. Xiao, and H.-L. Zhu. N-monoarylacetothioureas as potent urease inhibitors: synthesis, SAR, and biological evaluation. J. Enzyme Inhib. Med. Chem., 2020, 35(1), 404-413. https://doi.org/10.1080/14756366.2019.1706503
W.-W. Ni, H.-L. Fang, Y.-X. Ye, W.-Y. Li, C.-P. Yuan, D.-D. Li, S.-J. Mao, S.-E. Li, Q.-H. Zhu, H. Ouyang, Z.-P. Xiao, and H.-L. Zhu. N-monosubstituted thiosemicarbazide as novel Ure inhibitors: synthesis, biological evaluation and molecular docking. Future Med. Chem., 2020, 12(18), 1633-1645. https://doi.org/10.4155/fmc-2020-0048
W.-J. Mao, P.-C. Lv, L. Shi, H.-Q. Li, and H.-L. Zhu. Synthesis, molecular docking and biological evaluation of metronidazole derivatives as potent Helicobacter pylori urease inhibitors. Bioorg. Med. Chem., 2009, 17(21), 7531-7536. https://doi.org/10.1016/j.bmc.2009.09.018
K. M. Khan, F. Rahim, A. Khan, M. Shabeer, S. Hussain, W. Rehman, M. Taha, M. Khan, S. Perveen, and M. I. Choudhary. Synthesis and structure-activity relationship of thiobarbituric acid derivatives as potent inhibitors of urease. Bioorg. Med. Chem., 2014, 22(15), 4119-4123. https://doi.org/10.1016/j.bmc.2014.05.057
Z.-P. Xiao, W.-K. Shi, P.-F. Wang, W. Wei, X.-T. Zeng, J.-R. Zhang, N. Zhu, M. Peng, B. Peng, X.-Y. Lin, H. Ouyang, X.-C. Peng, G.-C. Wang, and H.-L. Zhu. Synthesis and evaluation of N-analogs of 1,2-diarylethane as Helicobacter pylori urease inhibitors. Bioorg. Med. Chem., 2015, 23(15), 4508-4513. https://doi.org/10.1016/j.bmc.2015.06.014
A. Rauf, S. Shahzad, M. Bajda, M. Yar, F. Ahmed, N. Hussain, M. N. Akhtar, A. Khan, and J. Jończyk. Design and synthesis of new barbituric- and thiobarbituric acid derivatives as potent urease inhibitors: Structure activity relationship and molecular modeling studies. Bioorg. Med. Chem., 2015, 23(17), 6049-6058. https://doi.org/10.1016/j.bmc.2015.05.038
I. Shabeeb, L. Al-Essa, M. Shtaiwi, E. Al-Shalabi, E. Younes, R. Okasha, and M. Abu Sini. New hydrazide-hydrazone derivatives of quinoline 3-carboxylic acid hydrazide: Synthesis, theoretical modeling and antibacterial evaluation. Lett. Org. Chem., 2019, 16(5), 430-436. https://doi.org/10.2174/1570178616666181227122326
K. Pyta, A. Janas, M. Szukowska, P. Pecyna, M. Jaworska, M. Gajecka, F. Bartl, and P. Przybylski. Synthesis, docking and antibacterial studies of more potent amine and hydrazone rifamycin congeners than rifampicin. Eur. J. Med. Chem., 2019, 167, 96-104. https://doi.org/10.1016/j.ejmech.2019.02.009
I. Amine Khodja, H. Boulebd, C. Bensouici, and A. Belfaitah. Design, synthesis, biological evaluation, molecular docking, DFT calculations and in silico ADME analysis of (benz)imidazole-hydrazone derivatives as promising antioxidant, antifungal, and anti-acetylcholinesterase agents. J. Mol. Struct., 2020, 1218, 128527. https://doi.org/10.1016/j.molstruc.2020.128527
A.-E. Dascalu, A. Ghinet, E. Lipka, C. Furman, B. Rigo, A. Fayeulle, and M. Billamboz. Design, synthesis and evaluation of hydrazine and acyl hydrazone derivatives of 5-pyrrolidin-2-one as antifungal agents. Bioorg. Med. Chem. Lett., 2020, 30(13), 127220. https://doi.org/10.1016/j.bmcl.2020.127220
H. He, X. Wang, L. Shi, W. Yin, Z. Yang, H. He, and Y. Liang. Synthesis, antitumor activity and mechanism of action of novel 1,3-thiazole derivatives containing hydrazide–hydrazone and carboxamide moiety. Bioorg. Med. Chem. Lett., 2016, 26(14), 3263-3270. https://doi.org/10.1016/j.bmcl.2016.05.059
E. M. Güngör, M. D. Altıntop, B. Sever, and G. A. Çiftçi. Design, Synthesis, in vitro and in silico evaluation of new hydrazonebased antitumor agents as potent akt inhibitors. Lett. Drug Des. Discovery, 2020, 17(11), 1380-1392. https://doi.org/10.2174/1570180817999200618163507
M. A. M. B. Medeiros, M. Gama e Silva, J. de Menezes Barbosa, É. Martins de Lavor, T. F. Ribeiro, C. A. F. Macedo, L. A. M. de Souza Duarte-Filho, T. A. Feitosa, J. de Jesus Silva, H. H. Fokoue, C. R. M. Araújo, A. de Assis Gonsalves, L. Augusto de Araújo Ribeiro, and J. R. G. da S. Almeida. Antinociceptive and anti-inflammatory effects of hydrazone derivatives and their possible mechanism of action in mice. PLoS One, 2021, 16(11), e0258094. https://doi.org/10.1371/journal.pone.0258094
M. Song, B. Liu, S. Yu, S. He, Y. Liang, S. Li, Q. Chen, and X. Deng. New hydrazone derivatives of pyrazole-4-carboxaldehydes exhibited anti-inflammatory properties. Lett. Drug Des. Discovery, 2020, 17(4), 502-511. https://doi.org/10.2174/1570180816666190731113441
F. Beygi, A. Mostoufi, and A. Mojaddami. Novel hydrazone derivatives of 3-bromopyruvate: synthesis, evaluation of the cytotoxic effects, molecular docking and ADME studies. Chem. Biodiversity, 2022, 19(6). https://doi.org/10.1002/cbdv.202100754
P. G. Avaji, C. H. Vinod Kumar, S. A. Patil, K. N. Shivananda, and C. Nagaraju. Synthesis, spectral characterization, in-vitro microbiological evaluation and cytotoxic activities of novel macrocyclic bis hydrazone. Eur. J. Med. Chem., 2009, 44(9), 3552-3559. https://doi.org/10.1016/j.ejmech.2009.03.032
S. U. Qazi, A. Naz, A. Hameed, F. A. Osra, S. Jalil, J. Iqbal, S. A. A. Shah, and A. Z. Mirza. Semicarbazones, thiosemicarbazone, thiazole and oxazole analogues as monoamine oxidase inhibitors: Synthesis, characterization, biological evaluation, molecular docking, and kinetic studies. Bioorg. Chem., 2021, 115, 105209. https://doi.org/10.1016/j.bioorg.2021.105209
Z.-X. He, J.-L. Huo, Y.-P. Gong, Q. An, X. Zhang, H. Qiao, F.-F. Yang, X.-H. Zhang, L.-M. Jiao, H.-M. Liu, L.-Y. Ma, and W. Zhao. Design, synthesis and biological evaluation of novel thiosemicarbazone-indole derivatives targeting prostate cancer cells. Eur. J. Med. Chem., 2021, 210, 112970. https://doi.org/10.1016/j.ejmech.2020.112970
B. Z. Sibuh, P. K. Gupta, P. Taneja, S. Khanna, P. Sarkar, S. Pachisia, A. A. Khan, N. K. Jha, K. Dua, S. K. Singh, S. Pandey, P. Slama, K. K. Kesari, and S. Roychoudhury. Synthesis, in silico study, and anti-cancer activity of thiosemicarbazone derivatives. Biomedicines, 2021, 9(10), 1375. https://doi.org/10.3390/biomedicines9101375
K. M. Khan, F. Rahim, A. Khan, S. Ali, M. Taha, S. M. Saad, M. Khan, Najeebullah, A. Shaikh, S. Perveen, and M. I. Choudhary. Synthesis of benzophenone hydrazone analogs and TH. J. Chem. Soc. Pak., 2015, 37(3), 479-483.
G. Akyüz, F. Ş. Beriş, B. Kahveci, and E. Menteşe. Synthesis of novel 2,3-disubstituted quinazolin-4(3H)-one derivatives containing hydrazone skeleton as potent urease inhibitors and their antimicrobial activities. J. Heterocycl. Chem., 2019, 56(11), 3065-3072. https://doi.org/10.1002/jhet.3703
S. Ahmad, M. Khan, M. I. A. Shah, M. Ali, A. Alam, M. Riaz, and K. M. Khan. Synthetic transformation of 2-{2-fluoro[1,1-biphenyl]-4-yl} propanoic acid into hydrazide–hydrazone derivatives: in vitro urease inhibition and in silico study. ACS Omega, 2022, 7(49), 45077-45087. https://doi.org/10.1021/acsomega.2c05498
M. Khan, G. Ahad, A. Manaf, R. Naz, S. R. Hussain, F. Deeba, S. Shah, A. Khan, M. Ali, K. Zaman, S. Zafar, U. Salar, A. Hameed, and K. M. Khan. Synthesis, in vitro urease inhibitory activity, and molecular docking studies of (perfluorophenyl)hydrazone derivatives. Med. Chem. Res., 2019, 28(6), 873-883. https://doi.org/10.1007/s00044-019-02341-5
J. Abdullah Al-Mohammadi, M. Taha, F. Rahim, R. Hussain, H. Aldossary, R. Khalid Farooq, A. Wadood, M. Nawaz, M. Salahuddin, K. Mohammed Khan, and N. Uddin. Synthesis, in vitro evaluation, and molecular docking studies of benzofuran based hydrazone a new inhibitors of urease. Arabian J. Chem., 2022, 15(8), 103954. https://doi.org/10.1016/j.arabjc.2022.103954
N. Baltaş. Synthesis of quinazolinone derivatives containing an acyl hydrazone skeleton as potent anti-urease agents enzyme kinetic studies and anti-oxidant properties. J. Chem. Res., 2022, 46(3), 174751982210965. https://doi.org/10.1177/17475198221096568
G. M. Morris, R. Huey, W. Lindstrom, M. F. Sanner, R. K. Belew, D. S. Goodsell, and A. J. Olson. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J. Comput. Chem., 2009, 30(16), 2785-2791. https://doi.org/10.1002/jcc.21256
SMART (Version 5.628) and SAINT (Version 6.02). Madison, Wisconsin, USA: Bruker AXS, 1998.
G. M. Sheldrick. SADABS: Program for Empirical Absorption Correction of Area Detector. Göttingen, Germany: University of Göttingen, 1996.
G. M. Sheldrick. A short history of SHELX. Acta Crystallogr., Sect. A: Found. Crystallogr., 2008, 64(1), 112-122. https://doi.org/10.1107/s0108767307043930
P. Nithya, J. Simpson, and S. Govindarajan. Template synthesis, structural variation, thermal behavior and antimicrobial screening of Mn(II), Co(II) and Ni(II) complexes of Schiff base ligands derived from benzyl carbazate and three isomers of acetylpyridine. Inorg. Chim. Acta, 2017, 467, 180-193. https://doi.org/10.1016/j.ica.2017.07.059
L. J. Farrugia and A. D. Khalaji. Evidence for side-chain π-delocalization in a planar substituted benzene: An experimental and theoretical charge density study on 2,5-dimethoxybenzaldehyde thiosemicarbazone. J. Phys. Chem. A, 2011, 115(45), 12512-12522. https://doi.org/10.1021/jp2026169
H.-J. Zhang, Y. Qian, D.-D. Zhu, X.-G. Yang, and H.-L. Zhu. Synthesis, molecular modeling and biological evaluation of chalcone thiosemicarbazide derivatives as novel anticancer agents. Eur. J. Med. Chem., 2011, 46(9), 4702-4708. https://doi.org/10.1016/j.ejmech.2011.07.016
V. Vrdoljak, M. Cindrić, D. Milić, D. Matković-Čalogović, P. Novak, and B. Kamenar. Synthesis of five new molybdenum(VI) thiosemicarbazonato complexes. Crystal structures of salicylaldehyde and 3-methoxy-salicylaldehyde 4-methylthiosemicarbazones and their molybdenum(VI) complexes. Polyhedron, 2005, 24(13), 1717-1726. https://doi.org/10.1016/j.poly.2005.05.002
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The authors declare that they have no conflicts of interests.
Additional information
Text © The Author(s), 2023, published in Zhurnal Strukturnoi Khimii, 2023, Vol. 64, No. 3, 107803.https://doi.org/10.26902/JSC_id107803
Rights and permissions
About this article
Cite this article
Han, YJ., Liu, QR. & Xue, LW. Synthesis, Characterization and Crystal Structures of Thiosemicarbazones with Urease Inhibitory Activity. J Struct Chem 64, 462–473 (2023). https://doi.org/10.1134/S0022476623030113
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0022476623030113